224 related articles for article (PubMed ID: 26801497)
21. A longitudinal study of BDNF promoter methylation and genotype with poststroke depression.
Kim JM; Stewart R; Kang HJ; Kim SY; Kim SW; Shin IS; Park MS; Kim HR; Shin MG; Cho KH; Yoon JS
J Affect Disord; 2013 Jul; 149(1-3):93-9. PubMed ID: 23399480
[TBL] [Abstract][Full Text] [Related]
22. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal.
Costa MA; Girard M; Dalmay F; Malauzat D
Alcohol Clin Exp Res; 2011 Nov; 35(11):1966-73. PubMed ID: 21848960
[TBL] [Abstract][Full Text] [Related]
23. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic alterations of the BDNF gene in combat-related post-traumatic stress disorder.
Kim TY; Kim SJ; Chung HG; Choi JH; Kim SH; Kang JI
Acta Psychiatr Scand; 2017 Feb; 135(2):170-179. PubMed ID: 27886370
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients.
Ikegame T; Bundo M; Sunaga F; Asai T; Nishimura F; Yoshikawa A; Kawamura Y; Hibino H; Tochigi M; Kakiuchi C; Sasaki T; Kato T; Kasai K; Iwamoto K
Neurosci Res; 2013 Dec; 77(4):208-14. PubMed ID: 23973796
[TBL] [Abstract][Full Text] [Related]
26. Cerebral metabolism in opiate-dependent subjects: effects of methadone maintenance.
Galynker II; Watras-Ganz S; Miner C; Rosenthal RN; Des Jarlais DC; Richman BL; London E
Mt Sinai J Med; 2000; 67(5-6):381-7. PubMed ID: 11064488
[TBL] [Abstract][Full Text] [Related]
27. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
[TBL] [Abstract][Full Text] [Related]
28. BDNF promoter methylation and genetic variation in late-life depression.
Januar V; Ancelin ML; Ritchie K; Saffery R; Ryan J
Transl Psychiatry; 2015 Aug; 5(8):e619. PubMed ID: 26285129
[TBL] [Abstract][Full Text] [Related]
29. Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.
Marie-Claire C; Jourdaine C; Lépine JP; Bellivier F; Bloch V; Vorspan F
Pharmacogenomics; 2017 Sep; 18(14):1359-1372. PubMed ID: 28841113
[TBL] [Abstract][Full Text] [Related]
30. Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy.
Peters L; Soyka M
Neuropsychobiology; 2019; 77(2):73-82. PubMed ID: 30453290
[TBL] [Abstract][Full Text] [Related]
31. Clinical update: codeine maintenance in opioid dependence.
Hall WD; Mattick RP
Lancet; 2007 Aug; 370(9587):550-2. PubMed ID: 17707737
[No Abstract] [Full Text] [Related]
32. Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism.
Zhou Z; Lu T; Xu G; Yue X; Zhu W; Ma M; Liu W; Zhu S; Liu X
Clin Chem Lab Med; 2011 Feb; 49(2):185-9. PubMed ID: 21143020
[TBL] [Abstract][Full Text] [Related]
33. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
[TBL] [Abstract][Full Text] [Related]
34. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels.
Ozan E; Okur H; Eker C; Eker OD; Gönül AS; Akarsu N
Brain Res Bull; 2010 Jan; 81(1):61-5. PubMed ID: 19589373
[TBL] [Abstract][Full Text] [Related]
35. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
Carboni L; Lattanzio F; Candeletti S; Porcellini E; Raschi E; Licastro F; Romualdi P
Neurosci Lett; 2015 Sep; 605():44-8. PubMed ID: 26275347
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of heroin-assisted treatment in Germany.
Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
[TBL] [Abstract][Full Text] [Related]
37. Heroin or conventional opioid maintenance? The patients' perspective.
Bald LK; Bermpohl F; Heinz A; Gallinat J; Gutwinski S
J Addict Med; 2013; 7(6):401-4. PubMed ID: 24145159
[TBL] [Abstract][Full Text] [Related]
38. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence.
Karow A; Verthein U; Pukrop R; Reimer J; Haasen C; Krausz M; Schäfer I
Subst Use Misuse; 2011; 46(6):705-15. PubMed ID: 21047149
[TBL] [Abstract][Full Text] [Related]
39. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
40. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
